back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-02-08 17:59 Tx date 2021-09-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,959
+15,000 vol $3.80 each |
43,981 | |
| Filed 2022-02-08 17:58 Tx date 2021-08-16 |
$DMAC
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$64,069
+20,721 vol $3.09 each |
28,981 | |
| Filed 2022-02-08 17:57 Tx date 2021-07-28 |
$DMAC
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+60,000 vol $5.00 each |
245,000 | |
| Filed 2022-02-08 17:55 Tx date 2018-08-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,000
+25,000 vol $0.52 each |
25,000 | |
| Filed 2018-08-24 13:57 Tx date 2018-08-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$260,000
+500,000 vol $0.52 each |
||
| Filed 2020-06-02 18:16 Tx date 2020-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
660,000 | |
| Filed 2019-08-19 15:18 Tx date 2019-08-16 |
$DMA
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,365
+7,260 vol $2.67 each |
8,260 | |
| Filed 2019-06-27 12:00 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
625,000 | |
| Filed 2018-12-11 Tx date 2018-12-11 |
$DMA
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
+1,000 vol |
1,000 | |
| Filed 2018-08-24 Tx date 2018-08-23 |
$DMA
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$260,000
+500,000 vol $0.52 each |
500,000 | |
| Filed 2018-08-24 Tx date 2018-08-06 |
$DMA
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-08 Tx date 2018-08-06 |
$DMA
DiaMedica Therapeutics Inc. |
Alcorn, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|